|
|
Cardiovascular Exchange Summit 2011
|
|
|
|
Extra-vascular inflammatory drive
|
|
|
|
Acute to Chronic inflammation
|
|
|
|
Atherosclerosis: fat accumulation in macrophages
|
|
|
|
|
Atheroma destabilisation
|
|
|
|
Atherothrombosis
|
|
|
|
Inflammation and coagulation
|
|
|
|
Inflammatory markers and CV-risk
|
|
|
|
LDL lowering in JUPITER
|
|
|
|
CRP lowering in JUPITER
|
|
|
|
Treatment of CID
|
|
|
|
Treatment of CID lowers risk
|
|
|
|
Even short-term MMF lowers plaque inflammation
|
|
|
|
Central role for macrophages
|
|
|
|
Plaque inflammation: Value of PET scanning
|
|
|
|
FDG Uptake: Modulation by Therapy
|
|
|
|
Local delivery of statins ?
|
|
|
|
[Statin]-rHDL slows atherosclerosis progression
|
|
|
|
Liposomal vs systemic prednisolon
|
|
|
|
Experimental model
|
|
|
|
|
|
|
|
|
Dalcetrapib and Atherosclerosis/inflammation: Dal-Plaque study
|
|
|
|
Change from Baseline in Average Carotid Total Vessel Area by MRI
|
|
|
|
PET-CT Data
|
|
|
|
Liposomal prednisolon in atherosclerotic disease?
|
|
|
|
SILENCE (phase I)
|
|
Deel deze pagina met collega's en vrienden: